Just submitted a refill?
Please allow 24 hours or call the pharmacy before picking up your prescription.
695 West Tefft Street, Suite A, Nipomo, CA 93444 | Phone: (805) 929-1929 | Fax: (805) 929-2041 | Mon-Fri 9:30am - 6:00pm | Sat 10:00am - 2:00pm | Sun Closed
Slide background Need a special medication?
We specialize in custom compounding.
More Information
Slide background Stay Healthy
We're here to help!
Patient Resources
Slide background Manage your family's medication
under one account!
Register Today!
Slide background Can't make it here?
We'll come to you!
Free Delivery
Slide background Looking for DME Products?

We offer a full-line of
durable medical equipment.
Manage your prescriptions securely online!

We want refilling your prescriptions to be easy and effortless. Sign up today to access your prescriptions, request refills and review drug details from the comfort of your home.

Your health is our priority.

We take our role in your health very seriously. Come in today to see how we can help.

Download iPhone App Download Android App Text Me A Link

Our commitment to patient care and health is priority one here at Nipomo Rexall Drug.

We believe in the value of providing personalized service and quality products.

JESSICA MASHAYEKHAN
Recent health news and videos.

Staying informed is also a great way to stay healthy. Keep up-to-date with all the latest health news here.

10 Dec

New Study Links Agent Orange to Rare Blood Cancer in Vietnam Vets

A landmark study finds Vietnam veterans exposed to Agent Orange face a significantly higher risk of developing myelodysplastic syndrome. Researchers hope this finding helps veterans get the health and disability benefits they’ve been denied for 50 years.

09 Dec

Do GLP-1 Drugs Affect Cancer Risk? New Study Says Probably Not

A review of 48 clinical trials on GLP-1 safety suggests the popular meds probably have little to no effect on cancer risk.

08 Dec

Two New Studies Find Strong Link Between Epilepsy and Depression

Depression not only makes epilepsy harder to treat but may also raise the risk of developing it, new research finds.

GLP-1 Medications Show Little Effect on Cancer, Study Shows

I. Edwards HealthDay Reporter December 10, 2025

GLP-1 Medications Show Little Effect on Cancer, Study Shows

A new study suggests popular GLP-1 drugs, like Ozempic and Zepbound, may not lower cancer risk as some had hoped.

Researchers analyzed 48 randomized trials including 94,245 adults who were overweight, obese or had type 2 diabetes. More than 51,000 people took a GLP-1 drug, and nearly 43,000 received a placebo and were followed for about 70... Full Page

Opioid Use Linked to Higher Risk of C. Diff Infection, Study Finds

I. Edwards HealthDay Reporter December 10, 2025

Opioid Use Linked to Higher Risk of C. Diff Infection, Study Finds

Taking opioids may make some patients more likely to develop a dangerous infection, new research suggests.

The infection is called Clostridioides difficile, or C. diff. It affects the colon and can spread easily, especially in hospitals and nursing homes. The illness can cause severe diarrhea, stomach pain, nausea and vom... Full Page

Many Young Americans Still Smoking Tobacco and Cannabis, Study Shows

I. Edwards HealthDay Reporter December 10, 2025

Many Young Americans Still Smoking Tobacco and Cannabis, Study Shows

Many young Americans are still smoking nicotine, tobacco or cannabis, even as edibles and vapes continue to grow in popularity.

A University of Michigan study looked at how 12- to 34-year-olds are using these substances today. Researchers examined data from 8,722 individuals who had used at least one of these products within the last 30 da... Full Page

AI Can Improve Epilepsy Treatment, Experts Argue

Dennis Thompson HealthDay Reporter December 10, 2025

AI Can Improve Epilepsy Treatment, Experts Argue

Artificial intelligence (AI) can help improve treatment of epilepsy by connecting the dots in complex cases, a new study says.

AI helped identify patients with drug-resistant epilepsy who might benefit from surgery, and it highlighted missing tests and evaluations that could better guide patients’ care, researchers reported in Atlant... Full Page

U.S. ERs Are Failing Sickle Cell Patients In Pain, Study Says

Dennis Thompson HealthDay Reporter December 10, 2025

U.S. ERs Are Failing Sickle Cell Patients In Pain, Study Says

U.S. emergency rooms are failing patients in severe pain from a sickle cell disease crisis, a new study says.

Only 1 in 3 patients in an ER for sickle cell crisis receive opioid painkillers within the first hour as treatment guidelines recommend, researchers reported Saturday in Orlando at an American Society of Hematology meeting.

A... Full Page

TikTok Videos On Gout Misleading, Inaccurate, Experts Say

Dennis Thompson HealthDay Reporter December 10, 2025

TikTok Videos On Gout Misleading, Inaccurate, Experts Say

Gout patients shouldn’t trust TikTok videos for advice on managing their condition, a new study says.

Most videos portray gout flares as a personal choice that can be alleviated through a healthy diet and less booze, researchers reported today in the journal Rheumatology Advances in Practice.

The videos fail to focus o... Full Page

HealthDay
Health News is provided as a service to Nipomo Rexall Drug site users by HealthDay. Nipomo Rexall Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.

Our Affiliations